Barr Takes Over Adderall IR From Shire
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC waiting period over, Barr will acquire the branded immediate-release version, but does not plan to promote it.
You may also be interested in...
Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.
Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.
Shire Settlement With Barr Permits Generic Adderall XR Entry In 2009
Questions over whether the deal will pass FTC muster demonstrate how jittery industry is becoming following a criminal probe into a Sanofi/Bristol agreement.